neurogenic detrusor overactivity
Showing 1 - 19 of 19
Neurogenic Bladder, Lower Urinary Tract Symptoms, Overactive Bladder Trial (Standard number of injection sites, Reduced number
Not yet recruiting
- Neurogenic Bladder
- +4 more
- Standard number of injection sites
- Reduced number of injection sites
- (no location specified)
Sep 22, 2023
Neurogenic Detrusor Overactivity Trial in Worldwide (mirabegron)
Not yet recruiting
- Neurogenic Detrusor Overactivity
-
Palo Alto, California
- +11 more
Jan 16, 2023
Neurogenic Detrusor Overactivity Trial in Worldwide (Mirabegron)
Completed
- Neurogenic Detrusor Overactivity
-
Randwick, New South Wales, Australia
- +31 more
Sep 21, 2022
Spinal Cord Injuries, Neurogenic Bladder, Neurogenic Detrusor Overactivity Trial (Neuromodulation)
Not yet recruiting
- Spinal Cord Injuries
- +3 more
- Neuromodulation
- (no location specified)
Aug 12, 2022
Neurogenic Detrusor Overactivity Trial in Colombia, United States (Darifenacin)
Terminated
- Neurogenic Detrusor Overactivity
-
San Diego, California
- +11 more
May 13, 2022
Overactive Bladder, Neurogenic Detrusor Overactivity Trial in Aalborg, Aarhus, Warsaw (mirabegron)
Completed
- Overactive Bladder
- Neurogenic Detrusor Overactivity
-
Aalborg, Denmark
- +2 more
Jun 28, 2021
Neurogenic Detrusor Overactivity Trial in Brussels (4 mg Fesoterodine ER tablet from Zwickau, 4 mg fesoterodine ER tablet from
Completed
- Neurogenic Detrusor Overactivity
- 4 mg Fesoterodine ER tablet from Zwickau
- +3 more
-
Brussels, Bruxelles-capitale, Région DE, BelgiumBrussels Clinical Research Unit
May 6, 2021
Neurogenic Detrusor Overactivity Trial in Brussels (Fesoterodine BIC SR4 fasted (Treatment A in Part A, Treatment G in Part B),
Completed
- Neurogenic Detrusor Overactivity
- Fesoterodine BIC SR4 fasted (Treatment A in Part A, Treatment G in Part B)
- +4 more
-
Brussels, Bruxelles-capitale, Région DE, BelgiumBrussels Clinical Research Unit
Feb 8, 2021
Neurogenic Detrusor Overactivity Trial in Worldwide (Rec 0/0438 1 mg or Rec 0/0438 2 mg, )
Completed
- Neurogenic Detrusor Overactivity
- Rec 0/0438 1 mg or Rec 0/0438 2 mg
- placebo
-
Praha, Czechia
- +8 more
Jan 26, 2021
Neurogenic Detrusor Overactivity, Spinal Cord Injury Trial in Badalona, Nottwil, Zurich (external electric pudendal nerve
Withdrawn
- Neurogenic Detrusor Overactivity
- Spinal Cord Injury
- external electric pudendal nerve stimulation
-
Badalona, Barcelona, Spain
- +2 more
Jul 19, 2019
Neurogenic Detrusor Overactivity Trial in Worldwide (Solifenacin succinate)
Completed
- Neurogenic Detrusor Overactivity
- Solifenacin succinate
-
Tarrytown, New York
- +20 more
Apr 10, 2019
Neurogenic Detrusor Overactivity, Pediatric Trial in Worldwide (Solifenacin succinate)
Completed
- Neurogenic Detrusor Overactivity
- Pediatric
- Solifenacin succinate
-
Tarrytown, New York
- +7 more
Oct 17, 2018
Overactive Bladder, Neurogenic Detrusor Overactivity Trial in Worldwide (Solifenacin succinate suspension 5 mg)
Completed
- Overactive Bladder
- Neurogenic Detrusor Overactivity
- Solifenacin succinate suspension 5 mg
-
Gent, Belgium
- +6 more
Oct 26, 2018
Is Nerve Growth FactorUseful Biomarker in Neurogenic Bladder
Completed
- Spinal Cord Injury
- +2 more
-
Nottwil, LU, SwitzerlandSwiss Paraplegic Centre
Nov 16, 2015
Spinal Cord Injury, Neurogenic Detrusor Overactivity Trial in Winnipeg, Toronto (Oxybutynin Cl, Trospium Cl, Darifenacin
Completed
- Spinal Cord Injury
- Neurogenic Detrusor Overactivity
- Oxybutynin Cl
- +2 more
-
Winnipeg, Manitoba, Canada
- +1 more
Apr 4, 2013
Overactive Bladder, Neurogenic Detrusor Overactivity Trial in United States (Fesoterodine)
Completed
- Overactive Bladder
- Neurogenic Detrusor Overactivity
-
Little Rock, Arkansas
- +8 more
Nov 20, 2011
Neurogenic Detrusor Overactivity Trial in Toronto (Botulinum toxin A)
Completed
- Neurogenic Detrusor Overactivity
- Botulinum toxin A
-
Toronto, Ontario, CanadaSunnybrook Health Sciences Centre
Mar 22, 2010